Literature DB >> 26641261

Mastoid Dimensions in Children and Young Adults: Consequences for the Geometry of Transcutaneous Bone-Conduction Implants.

Torsten Rahne, Sebastian Schilde, Ingmar Seiwerth, Florian Radetzki, Dietrich Stoevesandt, Stefan K Plontke.   

Abstract

OBJECTIVES: Bone-conduction implants (BCI) are available for adults and children who are aged 5 years or more. Because a transcutaneous bone-conduction implant introduced in 2013 does not completely fit into all adult mastoids, we investigated mastoid dimensions and the possibility of fitting the implant in children.
DESIGN: Computed tomography scans of 151 mastoids from 80 children and young adolescents from the age of 5 months to 20 years and 52 control mastoids from 33 adults were retrospectively analyzed. After three-dimensional reconstruction, mastoid volume was measured. The chances of fitting the Bonebridge or a novel BCI were determined as a function of age. Implant diameter and implantation depths were virtually varied to identify the most advantageous dimensions for reducing the minimum age for implantation.
RESULTS: Mastoid volume increased to 13.8 ml in female and 16.4 ml in male adult mastoids at ages 18.9 years (male) and 19.0 years (female). Without compromising the middle fossa dura or the sinus and without lifts, the Bonebridge implant fit in 81% of male adult mastoids and 77% of the female adult mastoids. For children, the 50% chance of fitting a Bonebridge in the mastoids was reached at age 12 years; with a protrusion of 4 mm (4-mm lifts), this age was reduced to >6 years. The novel BCI fit in 100% of male and 94% of female adult mastoids.
CONCLUSIONS: Casing diameter is the most limiting factor for Bonebridge implantation in children. A modified implant casing with a truncated cone and reduced diameter and volume would increase the number of hearing impaired children who can be rehabilitated with a Bonebridge implant. Radiological planning for Bonebridge implantation is necessary in all children.

Entities:  

Mesh:

Year:  2016        PMID: 26641261     DOI: 10.1097/MAO.0000000000000881

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Systematic radiographic evaluation of three potential implantation sites for a semi-implantable bone conduction device in 52 patients after previous mastoid surgery.

Authors:  Bernhard G Weiss; Mattis Bertlich; Rebecka Scheele; Martin Canis; Mark Jakob; Jan M Sohns; Friedrich Ihler
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-20       Impact factor: 2.503

2.  MRI after Bonebridge implantation: a comparison of two implant generations.

Authors:  Cristina Utrilla; Javier Gavilán; Pilar García-Raya; Miryam Calvino; Luis Lassaletta
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-23       Impact factor: 2.503

3.  A Comparative Study of a Novel Adhesive Bone Conduction Device and Conventional Treatment Options for Conductive Hearing Loss.

Authors:  Piotr H Skarzynski; Anna Ratuszniak; Kamila Osinska; Magdalena Koziel; Bartlomiej Krol; Katarzyna B Cywka; Henryk Skarzynski
Journal:  Otol Neurotol       Date:  2019-08       Impact factor: 2.311

Review 4.  Implantation of a new active bone conduction hearing device with optimized geometry.

Authors:  S K Plontke; G Götze; C Wenzel; T Rahne; R Mlynski
Journal:  HNO       Date:  2020-08       Impact factor: 1.284

5.  First Generation Osseointegrated Steady State Implant Benefits in Children With Hearing Loss.

Authors:  Karen A Gordon; Blake C Papsin; MaryLynn Feness; Jaina Negandhi; Sharon L Cushing
Journal:  Otol Neurotol       Date:  2022-03-01       Impact factor: 2.311

6.  Pediatric morphometric study to guide the optimized implantation of the Osia® 2 implant system.

Authors:  Balint Posta; Adam Perenyi; Linda Szabo; Roland Nagy; Gabor Katona; Zsuzsanna Csakanyi; Laszlo Rovo; Zsofia Bere
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-16       Impact factor: 3.236

7.  Clinical and functional results after implantation of the bonebridge, a semi-implantable, active transcutaneous bone conduction device, in children and adults.

Authors:  Ingmar Seiwerth; Laura Fröhlich; Sebastian Schilde; Gerrit Götze; Stefan K Plontke; Torsten Rahne
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-06       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.